The Merck Access Program
Merck
UnknownUnder review·Apr 24, 2026
- Covers
- financial assistance
- Enrollment cycle
- unknown
Eligibility
The program is available to U.S. residents diagnosed with Pulmonary Arterial Hypertension (Group 1) who meet clinical safety requirements including a minimum platelet count. Patients must undergo a benefits investigation and provide authorization for the disclosure of health information to determine eligibility for financial assistance or support services.
Apply
Application goes directly to Merck. RxCopays does not receive compensation.
Go to application →Status source
The provided content is not human-readable text, making it impossible to determine the enrollment status.
Rare-disease support beyond financial help
This grant covers 9 rare conditions. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: